Covid-19: Novavax vaccine shows 89% efficacy in UK trials

0
377

A new coronavirus vaccine has been shown to be 89.3% effective in large-scale UK trials. The Novavax jab is the first to show in trials that it is effective against the new virus variant found in the UK, the BBC’s medical editor Fergus Walsh said.

The PM welcomed the “good news” and said the UK’s medicines regulator would now assess the vaccine. The UK has secured 60 million doses of the jab, which will be made in Stockton-on-Tees in north-east England.

The doses are expected to be delivered in the second half of this year, if approved for use by the Medicines and Healthcare Products Regulatory Agency (MHRA), the government said.

The UK has so far approved three coronavirus vaccines for emergency use – one from Oxford University and AstraZeneca, another by Pfizer and BioNTech, and a third from drug firm Moderna.

LEAVE A REPLY

Please enter your comment!
Please enter your name here